{"id":"W3017596149","doi":"10.1111/cas.14430","title":"Budget impact analysis of treatment‐free remission in nilotinib‐treated Japanese chronic myeloid leukemia patients","year":2020,"lang":"en","type":"article","venue":"Cancer Science","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"Novartis Japan","keywords":"Nilotinib; Medicine; Myeloid leukemia; Tyrosine-kinase inhibitor; Internal medicine; Population; Imatinib; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002894585,0.000981784,0.001511122,0.000986998,0.0005670483,0.001870222,0.00126199,0.0011955,0.006143278],"category_scores_gemma":[0.008807787,0.0007414479,0.002348289,0.001515381,0.0004747565,0.001352898,0.001262292,0.001484765,0.0001891169],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007321198,"about_ca_system_score_gemma":0.007280391,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.06014203,"about_ca_topic_score_gemma":0.03083005,"domain_scores_codex":[0.9979419,0.001268461,0.00006647446,0.0001518221,0.0001169147,0.0004543515],"domain_scores_gemma":[0.9974184,0.001462772,0.0003177318,0.00008389993,0.0002697833,0.0004474379],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.001858344,0.00037366,0.02210921,0.0003295181,0.0006004845,0.0006751751,0.0001088963,0.9460554,0.0003528905,0.01339178,0.00362492,0.01051968],"study_design_scores_gemma":[0.0008279125,0.0008402484,0.01611654,0.0001567677,0.0009910914,0.0002472352,0.0005482231,0.9695387,0.0002593865,0.006340974,0.004058997,0.0000739078],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9419468,0.00421342,0.01667981,0.006097048,0.0001781745,0.0007032496,0.006241258,0.00008174196,0.02385845],"genre_scores_gemma":[0.9947784,0.0006406141,0.001623332,0.0002300776,0.00002288016,0.0001949824,0.001292817,0.00001273144,0.001204109],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06014203,"threshold_uncertainty_score":0.119584,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02238252583623937,"score_gpt":0.3183473209959485,"score_spread":0.2959647951597091,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}